
Receiving hours
giovedì 11.00-13.00 - prenotazione per email
Curriculum
Guido Antonelli has been a Full Professor of Microbiology and Clinical Microbiology at the Department of Molecular Medicine, Sapienza University of Rome, since 2002. He also currently serves as Chief of the Microbiology and Virology Unit (since 2004) and served as Head of the Department of Diagnostic Medicine and Radiology (2013–2024) at the University Hospital “Policlinico Umberto I” in Rome.
He began his academic career at the Institute of Virology, Sapienza University of Rome, in 1989, and subsequently held a position at the Department of Biomedicine, University of Pisa, in 1992. He also gained international experience through research appointments at the Department of Microbiology, University of Texas Medical Branch (Galveston, Texas, USA) in 1984, and at the Clinical Research Centre, Division of Immunological Medicine (Harrow, London, UK) in 1987.
His early research focused on the in vivo and in vitro mechanisms regulating the production and activity of interferons. Currently, his research group investigates the role of interferons as well as the pathogenesis, diagnosis, and control of several viral infections, including HIV, HCV, major respiratory viruses (such as SARS-CoV-2, RSV, and influenza viruses), and HPV. More recently, his research interests have expanded to include microbiological issues such as nosocomial infections and antimicrobial resistance.
He is actively involved in numerous national and international research projects, primarily focused on HIV, HCV, SARS-CoV-2, and antimicrobial resistance.
Professor Antonelli served for many years as President of SIVIM (Italian Society for Medical Virology) and currently holds the position of Vice-President of SIM (Italian Society for Microbiology).
He has authored or co-authored more than 350 peer-reviewed publications and currently serves as co-editor or editorial board member for several scientific journals, including Clinical Microbiology and Infection, Journal of Medical Virology, and JGAR, among others.